TRB Middle East

TRB Chemedica is a Swiss-based pharmaceutical company specializing in the research, development, and manufacturing of innovative treatments for rheumatology, ophthalmology, and neurology. The company is a pioneer in the field of hyaluronic acid-based therapies, producing well-known brands such as Ostenil for osteoarthritis and Vismed for dry eye syndrome. TRB Middle East serves as the regional hub for the Middle East and North Africa, managing the commercialization and distribution of the company's specialized portfolio. Their business model integrates the entire value chain, from basic research and patenting to international marketing and sales. With a focus on niche therapeutic areas, TRB Chemedica maintains a strong global presence through its subsidiaries and a network of distribution partners.